300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Travel
Local
Platforms
Retail
InsurTech
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Legal
Automotive
Wellness
eSports
Biotechnology
Education
Renewable Energy
Software
Facebook
Blockchain
Theatre
Beauty
Medical
Fashion
Web3
Infrastructure
Recruiting
Social
Celebrity
Food and Beverage
Life Science
Publishing
Wine and Spirits
Cannabis
Mobile Apps
Real Estate
Sporting Goods
LGBT
Music
Art
Finance
Climate
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Enterprise
Community
Proptech
Media (Entertainment)
Hardware
Transportation
Biotech
Sustainability
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Côte d'Ivoire
Costa Rica
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Mitsui Mining & Smelting, VC Fund

Mitsui Mining & Smelting

VC Fund

Tokyo, Japan

Mitsui Mining & Smelting is a VC fund in Tokyo focused on Medical and Therapeutics. Mitsui Mining & Smelting Company, Ltd. mainly produces non-ferrous metal such as lead and copper alloys.

Total investments:
6
Last investment:
Lead investor:
17%

Last updated:

Industries Mitsui Mining & Smelting invests in

MedicalTherapeuticsBiotechnologyPharmaceuticalWater

Stages Mitsui Mining & Smelting invests in

Series ASeries BVenture - Series Unknown

Countries Mitsui Mining & Smelting invests in

JapanUnited States

Round sizes

Series A $3.2M–$8MVenture - Series Unknown $22M–$29M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$3.2M–$8M
Venture - Series Unknown
$22M–$29M

Investment Focus

Industry

  • Medical 2 (33%)
  • Therapeutics 2 (33%)
  • Biotechnology 2 (33%)
  • Pharmaceutical 2 (33%)
  • Water 1 (17%)
See all 14 industries →

Stage

  • Series A 2 (33%)
  • Series B 2 (33%)
  • Venture - Series Unknown 1 (17%)

Country

  • Japan 4 (67%)
  • United States 1 (17%)

Team

NameTitleInvestmentsLinksEmail
Yoshi Kagawa
Yoshi Kagawa General Manager, CVC
General Manager, CVC Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei. Series B / Oct 09, 2026
WaHa has developed an innovative solid desiccant regeneration engine called the WaHa Vaporator®, which aims to revolutionize air conditioning technology. This patented system offers significant improvements in energy efficiency and greenhouse gas emissions for cooling, dehumidification, and atmospheric water generation applications.Key featuresof the WaHa Vaporator® include:- A novel approach to regenerating solid desiccants for air dehumidification - Independent control of dew point and dry bulb temperatures - Pure water generation, enabling direct evaporative cooling - Compatibility with ultra-low global warming potential refrigerants - Up to 90% reduction in energy consumption compared to conventional systems - Comparable size and weight to existing AC solutions and can be installed by current trades peopleThe WaHa Vaporator® is designed to be a versatile solution for air conditioning in any climate zones. It can also be used for cost-effective and energy efficient atmospheric water harvesting in any climate zone – including arid and cold climates. When compared to alternative technologies, it offers superior reliability and the lowest cost of ownership.WaHa was founded in 2018 to commercialize novel desiccant materials and technologies developed at UC Berkeley over two decades. The company has received seed funding from several sources, including UC Berkeley, Berkeley Catalyst Fund, Mitsui-Kinzoku, TAQNIA, and strategic angel investors. $8M / Series A / Jul 10, 2025
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. $28.6M / Venture - Series Unknown / Mar 10, 2025
Alpha Fusion produces astatine based radiopharmaceuticals for targeted alpha therapy. $6.9M / Series B / Oct 08, 2024
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. $22.5M / Venture - Series Unknown / Jul 13, 2023
Atomis provides global solutions for precisely controlling gases. Its core technology, porous coordination polymers (PCPs; also known as metal-organic frameworks (MOFs)), is based on research developed by Distinguished Professor Susumu Kitagawa at the Institute for Advanced Study at Kyoto University. It aims not only to provide solutions such asthe optimization for manufacturing processes of PCPs but to also develop applications that provide innovative value using these materials.It was founded by Masakazu Higuchi in 2015 and is headquartered in Kyoto, Japan. $3.2M / Series A / Jul 01, 2019

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Travel
Local
Platforms
Retail
InsurTech
Oil and Gas
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Sports
Legal
Automotive
Wellness
eSports
Biotechnology
Education
Renewable Energy
Software
Facebook
Blockchain
Theatre
Beauty
Medical
Fashion
Web3
Infrastructure
Recruiting
Social
Celebrity
Food and Beverage
Life Science
Publishing
Wine and Spirits
Cannabis
Mobile Apps
Real Estate
Sporting Goods
LGBT
Music
Art
Finance
Climate
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Enterprise
Community
Proptech
Media (Entertainment)
Hardware
Transportation
Biotech
Sustainability
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Tunisia
Taiwan
Zimbabwe
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Colombia
Armenia
China
Côte d'Ivoire
Costa Rica
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Moldova
Seychelles
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Mitsui Mining & Smelting invest in?

Mitsui Mining & Smelting invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Mitsui Mining & Smelting invest in?

Mitsui Mining & Smelting typically joins rounds of $3.2M–$8M at Series A and $22M–$29M at Venture - Series Unknown. These are whole funding-round sizes, not Mitsui Mining & Smelting's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Mitsui Mining & Smelting took part in.

How do I contact Mitsui Mining & Smelting?

Public channels for Mitsui Mining & Smelting include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Mitsui Mining & Smelting?

The team at Mitsui Mining & Smelting includes Yoshi Kagawa (General Manager, CVC). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Mitsui Mining & Smelting Mitsui Mining & Smelting Find emails